文献速递临床生化临床免疫质量管理与危急值

两种hCG即时检测设备的验证:i-STAT 1与AQT 90 FLEX

Ambulatory human chorionic gonadotrophin (hCG) testing: a verification of two hCG point of care devices.
PubMed 文献 · Clin Chem Lab Med · 2023-10-30

本研究在妊娠部位不明(PUL)分诊前,对i-STAT 1(Abbott)与AQT 90 FLEX(Radiometer)两种定量hCG即时检测设备进行前瞻性多中心验证,评估精密度、外部质量保证、相关性、钩状效应与回收率,并做可用性评估。两种设备均通过临床使用验证,但实用因素也需纳入选型考量。

要点

  • 两种hCG POCT设备均完成临床使用验证,可用于PUL分诊场景。
  • i-STAT 1的钩状效应出现浓度低于AQT,选择设备时需关注高浓度hCG样本。
  • i-STAT 1可用性评分低于AQT(90/130对121/130,p<0.001)。

核心结论

  • 两种hCG POCT设备均通过验证,可用于临床实践,但选型还需考虑实用因素。

研究设计与样本

  • 前瞻性多中心验证研究,对i-STAT 1(Abbott)与AQT 90 FLEX(Radiometer)两种定量hCG POCT设备进行精密度、外部质量保证、相关性、钩状效应与回收率检测,并同步开展POCT可用性评估。

主要发现

  • i-STAT 1三种室内质控品的变异系数为4.0–5.1%,AQT两种质控品为6.8–7.3%。
  • 与实验室及EQA定值相比,POCT EQA结果的对称差异i-STAT 1为3.2–24.5%,AQT为3.3–36.9%。
  • 使用合适全血样本时相关系数i-STAT 1为0.96、AQT为0.99,拟合优度曲线分别为0.92与0.99。
  • i-STAT 1钩状效应见于572,194–799,089 IU/L,低于AQT的799,089–1,619,309 IU/L。
  • 在各自验证样本类型中考虑红细胞压积后,hCG回收率i-STAT 1为108%、AQT为98%;可用性评分i-STAT 1为90/130,低于AQT的121/130(p<0.001,Mann-Whitney)。

关键数值与推荐

  • i-STAT 1室内质控变异系数4.0–5.1%,AQT为6.8–7.3%。
  • EQA对称差异i-STAT 1为3.2–24.5%,AQT为3.3–36.9%。
  • 相关系数i-STAT 1为0.96、AQT为0.99;拟合优度i-STAT 1为0.92、AQT为0.99。
  • 钩状效应i-STAT 1见于572,194–799,089 IU/L,AQT见于799,089–1,619,309 IU/L。
  • 回收率i-STAT 1为108%、AQT为98%;可用性评分i-STAT 1为90/130、AQT为121/130(p<0.001,Mann-Whitney)。

临床怎么用

  • 可在PUL分诊中使用经本次验证的hCG POCT设备,选型时除分析性能外还应评估可用性与钩状效应范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Quantitative human chorionic gonadotropin (hCG) measurements are used to manage women classified with a pregnancy of unknown location (PUL). Two point of care testing (POCT) devices that quantify hCG are commercially available. We verified the i-STAT 1 (Abbott) and the AQT 90 FLEX (Radiometer) prior to use in PUL triage. METHODS: Tests for precision, external quality assurance (EQA), correlation, hook effect and recovery were undertaken alongside a POCT usability assessment during this prospective multi-center verification. RESULTS: Coefficients of variation ranged between 4.0 and 5.1 % for the three i-STAT 1 internal quality control (IQC) solutions and between 6.8 and 7.3 % for the two AQT IQC solutions. Symmetric differences in POCT EQA results when compared with laboratory and EQA stock values ranged between 3.2 and 24.5 % for the i-STAT 1 and between 3.3 and 36.9 % for the AQT. Correlation coefficients (i-STAT 1: 0.96, AQT: 0.99) and goodness of fit curves (i-STAT 1: 0.92, AQT: 0.99) were excellent when using suitable whole blood samples. An hCG hook effect was noted with the i-STAT 1 between 572,194 and 799,089 IU/L, lower than the hook effect noted with the AQT, which was between 799,089 and 1,619,309 IU/L. When hematocrit concentration was considered in sample types validated for use with each device, hCG recovery was 108 % with the i-STAT 1 and 98 % with the AQT. The i-STAT 1 scored lower on usability overall (90/130) than the AQT (121/130, p<0.001, Mann-Whitney). CONCLUSIONS: Both hCG POCT devices were verified for use in clinical practice. Practical factors must also be considered when choosing which device to use in each unit.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Kyriacou C, Yang W, Kapur S, et al. Ambulatory human chorionic gonadotrophin (hCG) testing: a verification of two hCG point of care devices. Clin Chem Lab Med. 2023. PMID: 37886834. doi:10.1515/cclm-2023-0703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。